Non-steroidal Anti-inflammatory Analgesics for Acute Pain Management in Dogs and Cats

Summary

The recently developed non-steroidal anti-inflammatory drugs, discussed in this article, have been shown to be efficacious in controlling post-operative pain, used either alone or in combination with opioids, in both cats and dogs. In some instances selected non-steroidal anti-inflammatory analgesics appear to confer superior analgesia to opioids after orthopedic surgery. However, the side-effects of these drugs are an important factor in selecting the appropriate candidate to receive these analgesics. The contra-indications for use of non-steroidal anti-inflammatory drugs should be strictly adhered to. The trade names listed in this article may differ from those used in individual countries. The reader is advised to consult their own pharmacopea for trade names in the individual’s own country.

Recently developed, parenteral NSAIAs have been shown to be effective in managing postoperative pain in cats and dogs. In some instances, individual NSAIAs are equal to, and may be better than, opioid agonists in treating moderate to severe post-operative or medical pain. However, due to the concern for renal failure, gastric ulceration with hemorrhage and hemostatic abnormalities with individual NSAIA administration, caution must be used when selecting patients to receive these analgesics. Indications, relative contraindications and absolute contraindications for NSAIA use are discussed. A pain assessment scale (p. 128) with descriptors and suggestions for pain management are also discussed.

Keywords

Non-steroidal analgesics - cats - dogs - pain

• REFERENCES

• 1 Brock N. Treating moderate and severe pain in small animals. Can Vet J 1995; 36 (10) 658-60.
• 2 Quandt JE, Rawlings CR. Reducing postoperative pain for dogs: Local anesthetic and analgesic techniques. Comp Cont Educ Pract Vet 1996; 18 (02) 101-11.
• 3 Mathews KA. Special Report on Non-steroidal antiinflammatory analgesics for pain management in cats and dogs. Can Vet J 1996; 37 (09) 539-45.
• 4 Lees P, May SA, McKellar QA. Pharmacology and therapeutics of non-steroidal antiinflammatory drugs in the dog and cat: 1 General pharmacology. J Small Anim Pract 1991; 32: 183-93.
• 5 Malmberg NB, Yaksh L. Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J Pharmacol Exp Ther 1992; 263: 136-46.
• 6 Sigurdsson GH, Youssef H. Amelioration of respiratory and circulatory changes in established endotoxic shock by ketoprofen. Acta Anesthesiol Scand 1994; 38: 33-9.
• 7 Rainford KD. Mechanisms of NSAID-induced ulcerogenesis: Structural properties of drugs, focus on the microvascular factors, and novel approaches for gastro-intestinal protection. Acta Physiologica Hungarica 1992; 80 (1-4) 23-38.
• 8 Vane JR, Botting RM. New insights into mode of action of antiinflammatory drugs. Inflamm Res 1995; 44: 1-10.
• 9 Verbeeck RK. Pharmacokinetic drug interactions with nonsteroidal antiinflammatory drugs. Clin Pharmacokinet 1990; 19: 44-66.
• 10 Reid J, Nolan AM. A comparison of the postoperative analgesic and sedative effects of flunixin and papaveretum in the dog. J Small Anim Pract 1991; 32: 603-8.
• 11 Mathews KA, Paley DM, Foster RF, Valliant A. A comparison of ketorolac with flunixin, butorphanol, and oxymorphone in controlling postoperative pain in dogs. Can Vet J 1996; 37 (09) 557-67.
• 12 Hardie EM, Kolata RJ, Rawlings CA. Canine septic peritonitis; treatment with flunixin meglumine. Circ Shock 1983; 11 (02) 159-73.
• 13 Mathews KA, Doherty T, Dyson DH, Wilcock B, Valliant A. Nephrotoxicity in dogs associated with methoxyflurane anesthesia and flunixin meglumine analgesia. Can Vet J 1990; 31: 766-71.
• 14 Elwood C. Renal failure after flunixin meglumine administration. (Letter) Vet Rec 1992; 588 June 27.
• 15 Vonderhaar MA, Salisbury SK. Gastroduodenal ulceration associated with flunixin meglumine administration in three dogs. J Am Vet Med Assoc 1993; 201: 92-5.
• 16 McKellar QA, Delatour P, Lees P. Stereospecific pharmacodynamics and pharmaco-kinetics of carprofen in the dog. J Vet Pharm Thera 1994; 17 (06) 447-54.
• 17 Nolan A, Reid J. Comparison of the postoperative analgesic and sedative effects of carprofen and papaveretum in the dog. Vet Rec 1993; 133: 240-2.
• 18 Lascelles BDX, Butterworth SJ, Waterman AE. Postoperative analgesic and sedative effects of carprofen and pethidine in dogs. Vet Rec 1994; 134: 187-91.
• 19 Holtsinger RH, Parker RB, Beale BS, Friedman RL. The therapeutic efficacy of Carprofen (Rimadyl-V) in 209 clinical cases of canine degenerative joint disease. J Vet Comp Orthop Trauma 1992; 5: 140-4.
• 20 Rhone Merieux. Anafen Introducing a unique new-generation solution to age-old problems. Athens, Georgia 199.
• 21 Pibarot P. Personal Communication. School of Veterinary Medicine, University of Montreal, Ste. Hyacinth, Que
• 22 Glew A, Aviad AD, Keister DM, Meo NJ. Use of ketoprofen as an antipyretic in cats. Can Vet J 1996; 37: 222-5.
• 23 Litvakk KM, McEvoy GK. Drug Review. Ketorolac, an injectable nonnarcotic analgesic. Clin Pharm 1990; 9: 921-35.
• 24 Knapp DW, Richardson RC, Chan TCK. et al. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder. J Vet Intern Med 1994; 8: 273-8.
• 25 Goetzl EJ. Oxygenation products of arachidonic acid as mediators of hypersensitivity and inflammation. Med Clin North Am 1981; 65: 809-28.
• 26 Compendium of Pharmaceuticals and Specialties 29th ed. Krogh CME Editor-in-Chief, Canadian Pharmaceutical Association, Ottawa, Ontario Canada 1994
• 27 Murtaugh RJ, Matz ME, Labato MA, Boudrieau RJ. Use of synthetic prostaglandin E, (misoprostol) for prevention of aspirin-induced gastroduodenal ulceration in arthritic dogs. J Am Med Assoc 1993; 202 (02) 251-6.